Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Long who wrote (1347)	1/30/1998 2:10:00 AM
From: nonzeroa	Read Replies (2) \| Respond to of 2205

Congrats to the ATIS longs. Is the conditional approval for fresh or frozen Dermagraft? Anyone care to guesstimate/discuss future market shares/revenue ramp ups for ATIS vs ORG? What is the timing of the cartilage review?

To: Bruce Long who wrote (1347)	1/30/1998 7:19:00 AM
From: WWS	Read Replies (1) \| Respond to of 2205

Bruce, about ORG. I followed it only when it made "the news". Whenever Sturza made one of his frequent negative proclamations, "the news" was sure to follow. He was very convincing, at least to me. And I also remembered that one of the original ORG researchers got into trouble with NIH over data fabrication issues. Because of such facts I stayed away from ORG, and never could bring myself to grant it the "legitimacy" that I accorded to ATIS. Had I done anything it would have been to short, just as you did. I think that Sturza is going to have some serious explaining to do to salvage what is left of his reputation as "an expert". Bill.